| EMA number | EMEA/H/C/005591 |
| ATC code | R03AK06 |
| Authorisation | 26 March 2021 |
| Withdrawn | 23 May 2025 |
| Revision | 4 |
BroPair Spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting ?? agonists.